Syncona (LSE: SYNC) is a large British closed-ended investment trust dedicated to life science investments. Established in October 2012 as Battle Against Cancer Investment Trust ('BACIT'), the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Its chairman is Jeremy Tigue. The company has its own in-house management.
- "BACIT Changes Name To Syncona After Investment Shift". Morning Star. 19 December 2016. Retrieved 4 March 2017.
- "Annual Acoounts 31 March 2016" (PDF). BACIT. Retrieved 4 March 2014.